Antibodies from Ebola survivor could lead to treatments and vaccines


Check out a highlight of our work on pan-ebolavirus neutralizing antibodies in the NIH Research Matters newsletter. 

“Since it’s impossible to predict which of these agents will cause the next epidemic, it would be ideal to develop a single therapy that could treat or prevent infection caused by any known ebolavirus,” - Zach Bornholdt, PhD